A. Richard Green

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

B. Moreno Esteban, Esther O’Shea, Jorge Camarero et al. · Psychopharmacology · 2001 · 181 citations

Pharmacy, Pharmacology, Toxicology +14

NXY-059, a Free Radical–Trapping Agent, Substantially Lessens the Functional Disability Resulting From Cerebral Ischemia in a Primate Species

Jonathan Marshall, K J Duffin, A. Richard Green et al. · Stroke · 2001 · 180 citations

Medicine, Neuroscience, Pharmacology +17

Functional and Histological Evidence for the Protective Effect of NXY-059 in a Primate Model of Stroke When Given 4 Hours After Occlusion

Jonathan Marshall, Rosalyn M. Cummings, L. Bowes et al. · Stroke · 2003 · 131 citations · Full text

Medicine, Neuroscience, Pharmacology +16

3,4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion

Laura Orío, Esther O’Shea, Verónica Sánchez et al. · Journal of Neurochemistry · 2004 · 79 citations

Life Sciences, Neuroscience, Pharmacology +16

Studies, using <i>in vivo</i> microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum

Jorge Camarero, Verónica Sánchez, Esther O’Shea et al. · Journal of Neurochemistry · 2002 · 77 citations

Medicine, Neuroscience, Pharmacology +17